FDA Drug Application (202813) for QNASL by TEVA BRANDED PHARM

Back to FDA Applications sponsored by TEVA BRANDED PHARM

Application Number202813
Product Number001
FormAEROSOL, METERED;NASAL
Dosage0.08MG/ACTUATION
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameQNASL
Active IngredientBECLOMETHASONE DIPROPIONATE

Active IngredientCount
List of drugs with Active Ingredient BECLOMETHASONE DIPROPIONATE8


Back to FDA Applications sponsored by TEVA BRANDED PHARM